Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pyxis Oncology, Inc. (NASDAQ: PYXS)

 
PYXS Technical Analysis
5
As on 9th Jun 2023 PYXS STOCK Price closed @ 3.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.99 & Strong Sell for SHORT-TERM with Stoploss of 8.44 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PYXSSTOCK Price

Open 2.96 Change Price %
High 3.03 1 Day 0.03 1.01
Low 2.86 1 Week -0.22 -6.83
Close 3.00 1 Month 0.17 6.01
Volume 544997 1 Year -5.59 -65.08
52 Week High 11.43 | 52 Week Low 1.14
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
PYXS
Daily Charts		 PYXS
Intraday Charts		 Whats New @
Bazaartrend		 PYXS
Free Analysis
 
PYXS Important Levels Intraday
RESISTANCE3.33
RESISTANCE3.22
RESISTANCE3.16
RESISTANCE3.09
SUPPORT2.91
SUPPORT2.84
SUPPORT2.78
SUPPORT2.67
 
PYXS Forecast May 2024
Share
4th UP Forecast10.53
3rd UP Forecast8.12
2nd UP Forecast6.62
1st UP Forecast5.13
1st DOWN Forecast0.87
2nd DOWN Forecast-0.62
3rd DOWN Forecast-2.12
4th DOWN Forecast-4.53
 
PYXS Weekly Forecast
4th UP Forecast7.61
3rd UP Forecast6.13
2nd UP Forecast5.22
1st UP Forecast4.30
1st DOWN Forecast1.70
2nd DOWN Forecast0.78
3rd DOWN Forecast-0.13
4th DOWN Forecast-1.61
 
PYXS Forecast2024
4th UP Forecast23.04
3rd UP Forecast16.61
2nd UP Forecast12.64
1st UP Forecast8.67
1st DOWN Forecast-2.67
2nd DOWN Forecast-6.64
3rd DOWN Forecast-10.61
4th DOWN Forecast-17.04
 
 
PYXS Other Details
Segment EQ
Market Capital 423689216.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PYXS Address
PYXS
 
PYXS Latest News
 
Your Comments and Response on Pyxis Oncology, Inc.
 
PYXS Business Profile
Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal fibronectin extradomain-B for the treatment of non-small cell lung cancer; PYX-202, a site-specific investigational ADC targeting delta like non-canonical notch ligand 1 to treat small cell lung cancer, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational site-specific ADC targeting CD123 for the treatment of acute myeloid leukemia and other blood cancers. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service